Tourmaline Bio, Inc. (TRML)
NASDAQ: TRML · Real-Time Price · USD
17.88
-0.12 (-0.67%)
Jan 21, 2025, 4:00 PM EST - Market closed
Tourmaline Bio Market Cap
Tourmaline Bio has a market cap or net worth of $458.49 million as of January 21, 2025. Its market cap has decreased by -13.89% in one year.
Market Cap
458.49M
Enterprise Value
176.86M
1-Year Change
-13.89%
Ranking
Category
Stock Price
$17.88
Market Cap Chart
Since October 20, 2023, Tourmaline Bio's market cap has increased from $221.67M to $458.49M, an increase of 106.83%. That is a compound annual growth rate of 79.14%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 17, 2025 | 461.57M | -11.24% |
| Dec 31, 2024 | 520.03M | -2.33% |
| Dec 29, 2023 | 532.42M | 140.18% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 653.46B |
| UnitedHealth Group | 469.12B |
| Johnson & Johnson | 353.99B |
| Novo Nordisk | 352.70B |
| AbbVie | 303.17B |
| Merck & Co. | 247.70B |
| Thermo Fisher Scientific | 214.07B |
| Intuitive Surgical | 211.09B |